Join
Live feed
·
PRReleasevia Quantisnow
Prelude Therapeutics Incorporated logo

Prelude Therapeutics Reports Full Year 2025 Financial Results and Provides Program Outlook for 2026

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PRLD (Prelude Therapeutics Incorporated) and more on Quantisnow.